Biocon’s Avastin Biosimilar To Put The Heat On Competition?

Profit
BIOCON HAS LAUNCHED ITS CUT-PRICE AVASTIN BIOSIMILAR • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip